Target intelligence / Profile preview

Pseudomonas aeruginosa Psl exopolysaccharide (None)

Target
None
Molecular classification
Exopolysaccharide, Polysaccharide
01

Overview

Psl is a key exopolysaccharide produced by *Pseudomonas aeruginosa*, a Gram-negative opportunistic pathogen known for its robust biofilm formation and resistance to antibiotics. Psl plays a central role in the initial attachment of bacterial cells to surfaces, cell-to-cell interactions, and the maintenance of mature biofilm structure. The repeating unit of Psl is a neutral, branched pentasaccharide composed primarily of D-mannose, D-glucose, and L-rhamnose. Biosynthesis of Psl is directed by the psl operon (pslA-O), which encodes at least 12 proteins involved in its assembly and export. Psl is essential for initial surface attachment during early biofilm development and provides structural stability to mature biofilms. It also interferes with complement deposition, inhibits neutrophil functions, and enhances intracellular survival within phagocytes. Production is stimulated by elevated levels of c-di-GMP, which creates a positive feedback loop. Certain bacteriophages specifically recognize Psl on the bacterial surface and can disrupt established biofilms.

02

Mechanism of action

Bacteriophages disrupt biofilms by targeting bacteria expressing Psl exopolysaccharide.

03

Biological functions

Biofilm formationSurface attachmentCell-cell interactionsImmune evasionPhage receptor
04

Disease associations

InfectionChronic infectionBiofilm-associated infections
05

Safety considerations

Potential for resistance development in *P. aeruginosa*.Complexity of biofilm matrix makes complete eradication challenging.
06

Interacting drugs

Bacteriophages (targeting Psl)

Beyond the preview

Go deeper on Pseudomonas aeruginosa Psl exopolysaccharide (None).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pseudomonas aeruginosa Psl exopolysaccharide (None).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call